QA: Flexion Therapeutics Inc in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001419600_2021_Flexion_Therapeutics_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001419600, Flexion Therapeutics Inc

  xvar xval
0 AssetsCurrent 225,811,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 19,538,000
3 remainder_Assets 6,577,000
4 LiabilitiesCurrent 55,268,000
5 LiabilitiesNoncurrent 50,532,000
6 remainder_Liabilities 162,786,000
7 CostOfGoodsAndServicesSold 38,428,077
8 SellingGeneralAndAdministrativeExpense 61,502,817
9 ResearchAndDevelopmentExpense 53,952,548
10 remainder_Expenses 324,843
11 remainder_Revenues 101,818,062
12 remainder_NetIncome -53,460,197
13 remainder_ComprehensiveNetIncome 6,530
  yvar yval
0 Assets 251,926,000
1 Liabilities 268,586,000
2 Expenses 154,208,285
3 Revenues 101,818,062
4 StockholdersEquity -16,660,000
5 NetIncome -105,850,420
6 ComprehensiveNetIncome -105,847,155
7 BaseVar 415,002,537
8 EconomicCapitalRatiobeforeLimitedLiability -0.546
9 EconomicCapitalRatio 1.38

Edgar->Model Mapping

Feature Distribution

Change over Time